Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis.

MLA

Ghadieh, Hilda E., et al. “Hyperinsulinemia Drives Hepatic Insulin Resistance in Male Mice with Liver-Specific Ceacam1 Deletion Independently of Lipolysis.” Metabolism: Clinical and Experimental, vol. 93, Apr. 2019, pp. 33–43. EBSCOhost, https://doi.org/10.1016/j.metabol.2019.01.008.

APA

Ghadieh, H. E., Russo, L., Muturi, H. T., Ghanem, S. S., Manaserh, I. H., Noh, H. L., Suk, S., Kim, J. K., Hill, J. W., & Najjar, S. M. (2019). Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis. Metabolism: Clinical and Experimental, 93, 33–43. https://doi.org/10.1016/j.metabol.2019.01.008

Chicago

Ghadieh, Hilda E, Lucia Russo, Harrison T Muturi, Simona S Ghanem, Iyad H Manaserh, Hye Lim Noh, Sujin Suk, Jason K Kim, Jennifer W Hill, and Sonia M Najjar. 2019. “Hyperinsulinemia Drives Hepatic Insulin Resistance in Male Mice with Liver-Specific Ceacam1 Deletion Independently of Lipolysis.” Metabolism: Clinical and Experimental 93 (April): 33–43. doi:10.1016/j.metabol.2019.01.008.